Table 4 The associated factors with at least one solicited local or systemic adverse effects (AE) in multiple logistic regression models

Age

0.97 (0.97–0.98)

< 0.001

0.98 (0.97–0.98)

< 0.001

0.98 (0.97–0.98)

< 0.001

0.99 (0.99–1.00)

0.298

Female sex

2.65 (2.29–3.07)

< 0.001

1.78 (1.55–2.04)

< 0.001

2.07 (1.76–2.43)

< 0.001

1.69 (1.45–1.98)

< 0.001

Prior COVID-19

1.32 (1.17–1.50)

< 0.001

1.20 (1.07–1.35)

0.001

1.07 (0.94–1.22)

0.291

1.08 (0.96–1.23)

0.187

Vaccine brands

 Sinopharm

Reference

–

Reference

–

Reference

–

Reference

–

 Sputnik V

4.74 (3.90–5.76)

< 0.001

2.54 (2.11–3.06)

< 0.001

3.64 (2.91–4.55)

< 0.001

3.19 (2.55–3.99)

< 0.001

 AZD1222

8.73 (6.93–10.99)

< 0.001

6.79 (5.39–8.57)

< 0.001

4.14 (3.32–5.17)

< 0.001

2.56 (2.06–3.18)

< 0.001

 COVIran Barekat

1.00 (0.83–1.20)

0.969

0.56 (0.46–0.67)

< 0.001

2.98 (2.29–3.87)

< 0.001

1.10 (0.85–1.44)

0.443

Comorbidities

 Allergy

2.18 (1.16–4.08)

0.015

2.47 (1.34–4.56)

0.004

NR

–

NR

–

 Hypertension

1.25 (1.02–1.55)

0.032

NR

–

NR

–

NR

–

 Cardiac diseases

NR

–

1.55 (1.22–1.97)

< 0.001

NR

–

NR

–

 Cancer

NR

–

1.73 (1.13–1.91)

0.006

NR

–

1.87 (1.25–2.80)

0.002